Acne

21 stories · following the connections

Business

Novan Licenses SB204 to Sato for Acne in Japan

By Nasdaq OMXJan 17, 2017, 2:05 PM UTC

Business

Novan to Present Data from SB204 Phase 2b Trial at Fall Clinical Dermatology Conference

By Nasdaq OMXOct 18, 2016, 1:05 PM UTC

Business

Dermira to Present at 15th Annual Needham Healthcare Conference

By Nasdaq OMXApr 5, 2016, 11:30 AM UTC

Business

Dermira to Present at the Leerink Partners 5th Annual Global Healthcare Conference

By Nasdaq OMXFeb 4, 2016, 12:00 PM UTC

Business

Dermira Provides DRM01 and DRM04 Development Program Updates

By Nasdaq OMXJan 7, 2016, 9:05 PM UTC